|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Levaquin, RW Johnson NDA 20-634, S004 & 20-635, S003 12/17/98 7/2/99
Levaquin Indications: uncomplicated urinary tract infection (UTI)
Levaquin (levofloxacin) Tablets & Injection, Johnson & Johnson Pharmaceutical NDA 20-634/S28 & 20-635/S27 10/23/03
Levaquin (levofloxacin) Tablets & Injection, R.W. Johnson Pharmaceutical Research
Institute NDA 20-634/S25 & 20-635/S22 10/30/02 1/29/03 10/31/02
Levaquin (levofloxacin) Tablets & Injection, R.W. Johnson Pharmaceutical Research
Institute NDA 20-634/S15, S21 & S22 & 20-635/S12, S19 & S20 12/18/01 2/12/01 2/12/01
Levaquin (levofloxacin) Tablets & Injection, 250mg, 500mg, & 750mg / IV - 25mg/mL; 20 & 30mL(new) vials 5mg/mL; 50, 100, & 150mL(new), R.W. Johnson Pharmaceutical Research
Institute NDA 20-634/S-013 & 20-635/S-010 9/8/00 9/12/00 9/12/00
Levaquin Indication: Treatment of complicated skin and skin structure infections.
Levaquin Tablets,250mg and 500mg / Levaquin Injection,25mg/ml and 5mg/ml, R.W. Johnson Pharmaceutical Research
Institute NDA 20-634/S-008 & 20-635/S-007 2/2/00 2/3/00
Levaquin Indication: Treatment of levofloxacin-susceptible strains of penicillin-resistant Steptococcus pneumoniae in patients with community acquired pneumonia. Quixin (levofloxacin ophthalmic solution), 0.5%, Santen Incorporated NDA 21-199/S3 6/4/02 6/17/02 6/7/02
Quixin (levofloxacin ophthalmic solution), 0.5%, Santen Incorporated NDA 21-199/S2 4/18/02 4/22/02 4/18/02
Quixin (levofloxacin ophthalmic solution) Sterile, 0.5%, Santen Incorporated NDA 21-199 8/18/00 8/28/00 8/28/00
Quixin Indications: treatment of bacterial conjunctivitis. Levaquin (levofloxacin) Tablets & Injection, Johnson & Johnson Pharmaceutical LEVOFLOXACIN Injection 25MG/ML LEVAQUIN ORTHO MCNEIL 020635 LEVOFLOXACIN Injection 500MG/100ML LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER ORTHO MCNEIL 020635 LEVOFLOXACIN Injection 5MG/ML LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER ORTHO MCNEIL 021199 LEVOFLOXACIN Solution/Drops; Ophthalmic 0.5% QUIXIN SANTEN
020634 LEVOFLOXACIN Tablet; 250MG LEVAQUIN ORTHO MCNEIL 020634 LEVOFLOXACIN Tablet; 500MG LEVAQUIN ORTHO MCNEIL 020634 LEVOFLOXACIN Tablet; 750MG LEVAQUIN ORTHO MCNEIL Iquix (Levofloxacin) Opthalmic Solution, Santen Incorporated Levaquin (levofloxacin) Tablets & Injection, R.W. Johnson Pharmaceutical Levofloxacin Tablets, Teva Pharmaceuticals, Levofloxacin Injection, Bedford Laboratories | Levofloxacin Tablets, Ranbaxy, Inc., Tentative Approval | LEVAQUIN (levofloxacin) Injection, R.W. Johnson Pharmaceutical, Labeling Revision
| LEVAQUIN (levofloxacin) Tablets R.W. Johnson Pharmaceutical, Labeling Revision | Levofloxacin Tablets, Myland Pharma, Approval | Levaquin (Levofloxacin) Oral Solution, J & J Pharmaceuticals, Approval | LEVAQUIN (levofloxacin) Tablets, Ortho McNeil Pharma, Labeling Revision
| LEVAQUIN (levofloxacin) Injection, Ortho McNeil Pharma, Labeling Revision | Levaquin (Levofloxacin) Tablets, Ortho-McNeil, New or Modified Indication
| Levaquin (Levofloxacin) Injection, Ortho-McNeil, New or Modified Indication
| Levaquin (Levofloxacin) Oral Solution, Ortho-McNeil, New or Modified Indication | Levofloxacin Tablet (750mg), Teva Pharma, Approval | Levofloxacin Injection, Sicor Pharma, Tentative Approval | Levofloxacin Tablets, Mylan Pharma, Tentative Approval | Levofloxacin Ophthalmic Solution, Hi-Tech Pharmacal, Tentative Approval | Quixin (levofloxacin ophthalmic solution), Santen Inc., Labeling Revision & Package Change | Levofloxacin Tablets, Dr. Reddy's Labs, Tentative Approval | Levofloxacin Tablets, IVAX Pharma, Tentative Approval | Levofloxacin (in 0.9% sodium chloride) Injection, SICOR Pharma, Approval | Levaquin (Levofloxacin) Tablet, Ortho McNeil Pharma, New Dosage Regimen | Levaquin (Levofloxacin) Injection, Ortho McNeil Pharma, New Dosage Regimen | Levaquin (Levofloxacin) Oral Suspension, Ortho McNeil Pharma, New Dosage Regimen | Levaquin (Levofloxacin) Tablets, Ortho McNeil Pharma, Labeling Revision | Levaquin (Levofloxacin) Injection, Ortho McNeil Pharma, Labeling Revision | Levaquin (Levofloxacin) Oral Solution, Ortho McNeil Pharma, Labeling Revision | Levofloxacin Tablets, Zydus Pharma, Tentative Approval | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Labeling Revision
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|